Composition containing bacterium belonging to genus bifidobacterium as active ingredient

Abstract

The present invention addresses the problem of providing a composition for preventing the adsorption of a bacterium belonging to the genus Fusobacterium to a mucosal cell; and a pharmaceutical composition and a food or beverage composition for preventing or treating a disease or condition that is associated with the inflammation of a mucosal cell and is selected from the group consisting of ulcerative colitis, colorectal cancer, esophagus cancer, premature birth and periodontal disease. The problem can be solved by the composition for preventing the adsorption of a bacterium belonging to the genus Fusobacterium to a mucosal cell, which contains a bacterium belonging to the genus Bifidobacterium as an active ingredient; and the pharmaceutical composition and the food or beverage compositionfor preventing or treating a disease or condition that is associated with the inflammation of a mucosal cell and is selected from the group consisting of ulcerative colitis, colorectal cancer, esophagus cancer, premature birth and periodontal disease, which contains a bacterium belonging to the genus Bifidobacterium as an active ingredient.

Description

technical field [0001] The present invention relates to a composition for inhibiting the adsorption of Fusobacterium bacteria to mucosal cells. In addition, the present invention relates to a product selected from the group consisting of ulcerative colitis, colorectal cancer, esophagus cancer, premature birth and periodontal disease, which contains bacteria of the genus Bifidobacterium as an active ingredient and is used for preventing or treating inflammation caused by mucosal cells. A pharmaceutical composition and a food composition for a disease or symptom in the present invention. Background technique [0002] Bacteria belonging to the genus Bifidobacterium are known to be effective in the prevention, treatment, improvement, etc. of human diseases and symptoms. [0003] For example, Bifidobacterium bifidum G9-1 is known to be effective in the prevention or treatment of 5-fluorouracil-induced intestinal diseases (Patent Document 1). [0004] In addition, it is known th...

AI Technical Summary

Problems solved by technology

[0010] In addition, it was reported that the presence of Fusobacterium was confirmed in 325 cases of esophageal cancer tissues, and as a resu

Images